White label – Pompe disease - ClinicalTrials.eu

Study on Lomustine and Temozolomide for Newly Diagnosed Glioblastoma Patients

Recruiting

3 1 1 1
Investigated Drugs:
- Temozolomide
Study on the Effects of Rilvegostomig and Drug Combination for Patients with Advanced Gastric or Gastroesophageal Junction Cancer

Recruiting

2 1 1 1
Investigated Diseases:
- Adenocarcinoma gastric
- Oesophageal adenocarcinoma
Investigated Drugs:
Study on Nitrous Oxide and Oxygen for Treating Depression in Nursing Home Residents with Neurocognitive Disorders

Recruiting

2 1 1 1
Investigated Diseases:
- Cognitive disorder
Investigated Drugs:
Study on the Safety and Tolerability of STK-002 for Patients with Autosomal Dominant Optic Atrophy

Recruiting

1 1 1
Investigated Diseases:
- Hereditary optic atrophy
Investigated Drugs:
- 18‐Mer Antisense Oligonucleotide Complementary To Opa1 Pre-Mrna
Study on Low-Dose Aldesleukin for Patients with Pemphigus, Mucous Membrane Pemphigoid, Polymyositis, Dermatomyositis, and Primary Sclerosing Cholangitis

Recruiting

2 1 1
Investigated Diseases:
Investigated Drugs:
- Aldesleukin
- Glucose
Study on the Safety and Effectiveness of Baricitinib for Children Aged 1 to 17 with Juvenile Idiopathic Arthritis

Recruiting

3 1 1 1
Investigated Drugs:
- Baricitinib
+3
Study on the Safety and Effectiveness of Lufepirsen Gel for Patients with Persistent Corneal Epithelial Defects

Recruiting

2 1
Investigated Diseases:
- Persistent corneal epithelial defect
Investigated Drugs:
- Lufepirsen
Study on Glioblastoma Treatment with Olaptesed Pegol and Radiation, with Bevacizumab or Pembrolizumab, for Patients with Unmethylated MGMT Promoter

Recruiting

1 1 1 1
Investigated Diseases:
- Glioblastoma
Investigated Drugs:
Study on Golcadomide for Patients with Relapsed or Refractory Aggressive Large B-Cell Lymphoma at High Risk of Relapse After CAR T-Cell Therapy

Recruiting

2 1 1 1
Investigated Diseases:
- Diffuse large B-cell lymphoma
Investigated Drugs:
Study on the Safety and Tolerability of D3S-001 Alone or with Drug Combination in Adults with Advanced Solid Tumors with KRAS p.G12C Mutation

Recruiting

2 1 1 1
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies